Singular Genomics Systems's quarterly market cap
increased
from Sep. 2023 ($27.94 Mil) to Dec. 2023 ($33.97 Mil) and
increased
from Dec. 2023 ($33.97 Mil) to Mar. 2024 ($38.09 Mil).
Singular Genomics Systems's annual market cap
declined
from Dec. 2021 ($837.39 Mil) to Dec. 2022 ($144.43 Mil) and
declined
from Dec. 2022 ($144.43 Mil) to Dec. 2023 ($33.97 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Singular Genomics Systems's Enterprise Value for Today is $-51.64 Mil.
Singular Genomics Systems Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Singular Genomics Systems's Market Cap
For the Medical Instruments & Supplies subindustry, Singular Genomics Systems's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Singular Genomics Systems's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Singular Genomics Systems's Market Cap distribution charts can be found below:
* The bar in red indicates where Singular Genomics Systems's Market Cap falls into.
Singular Genomics Systems Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Singular Genomics Systems (NAS:OMIC) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Singular Genomics Systems Market Cap Related Terms
Thank you for viewing the detailed overview of Singular Genomics Systems's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Singular Genomics Systems (Singular Genomics Systems) Business Description
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OMIC has been successfully added to your 